UPDATED May 15, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CLBIO | kr10.10 | 0.5% | -35.9% | kr217.1m | kr29.00 | PS7x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
XBRANE | kr0.22 | 16.3% | -99.7% | kr338.8m | n/a | PS1.4x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr118.50 | 5.8% | 13.9% | kr6.4b | kr208.00 | PS5.3x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
SPAGO | kr0.26 | -8.1% | -65.8% | kr58.4m | n/a | PS9.9x | E52.1% | n/a | Pharmaceuticals & Biotech | ||
ECC B | kr3.16 | 19.2% | -30.4% | kr146.1m | kr8.50 | PB0.6x | E77.3% | n/a | Capital Goods | ||
ORX | kr19.80 | 3.1% | 88.9% | kr682.1m | kr24.00 | PS1.1x | E77.5% | n/a | Pharmaceuticals & Biotech | ||
EGTX | kr6.72 | 10.0% | -11.7% | kr2.0b | kr14.30 | PS31.3x | E98.4% | n/a | Pharmaceuticals & Biotech | ||
SUN4 | kr6.38 | -1.8% | -45.0% | kr125.2m | kr29.00 | PE16.4x | E49.6% | n/a | Capital Goods | ||
DIGN | kr1.53 | -5.6% | -57.5% | kr107.8m | kr8.60 | PS1.3x | E139.0% | n/a | Healthcare | ||
SGG | kr78.00 | 0% | 18.2% | kr899.4m | kr110.00 | PE44x | E52.7% | n/a | Tech | ||
MAHA A | kr8.71 | -1.5% | 2.1% | kr1.6b | kr12.75 | PS36.8x | E55.0% | n/a | Energy | ||
VERT B | kr42.20 | -3.0% | 61.1% | kr865.2m | kr50.00 | PE42.6x | E26.9% | 0% | Software | ||
SENZA | kr8.98 | -5.5% | -23.9% | kr217.2m | kr17.75 | PS4.4x | E84.0% | n/a | Pharmaceuticals & Biotech | ||
OVZON | kr17.84 | 22.9% | -44.3% | kr2.0b | kr11.50 | PS6.4x | E91.3% | n/a | Telecom | ||
ACROUD | kr0.90 | -3.0% | -55.7% | kr156.0m | kr1.90 | PB5.7x | E101.7% | n/a | Consumer Services | ||
NOHARM | kr0.13 | -3.4% | -61.3% | kr37.7m | n/a | PB0.9x | E121.6% | n/a | Food, Beverage & Tobacco | ||
DVYSR | kr102.00 | 3.0% | 27.5% | kr1.7b | kr126.15 | PS9.2x | E99.0% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | kr3.12 | 2.0% | -44.7% | kr75.7m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
PREC | kr1.74 | 24.0% | -2.3% | kr134.3m | kr2.70 | PS1.8x | E80.4% | n/a | Software | ||
MEDHLP | kr3.00 | -2.6% | -25.2% | kr91.3m | n/a | PS1x | E87.4% | n/a | Healthcare | ||
CANDLE B | kr23.00 | -9.1% | -31.3% | kr199.0m | kr42.00 | PS1.2x | E125.3% | n/a | Consumer Durables | ||
SKOLON | kr22.00 | -2.7% | -19.1% | kr584.0m | kr27.50 | PE85.7x | E67.4% | 2.5% | Software | ||
CLEM | kr0.94 | 6.8% | -8.7% | kr129.6m | kr1.45 | PE13x | E22.3% | 0% | Household | ||
W5 | kr73.60 | 0.8% | -18.4% | kr1.1b | kr104.00 | PS2.6x | E83.0% | n/a | Capital Goods |